180 Life Sciences Provides Update on Regulatory Approval Process in the UK and US for Dupuytren's Disease Treatment; Continues Consultations with the UK MHRA and Initiates a Type C Meeting Request With the US FDA
Stock Information for 180 Life Sciences Corp.
Loading
Please wait while we load your information from QuoteMedia.